2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Dermatologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Melanoma
1
Adenoviridae Infections
1
Interventions
pembrolizumab
1285
Specimen Handling
928
Carboplatin
837
Magnetic Resonance Spectroscopy
834
Cyclophosphamide
808
Cisplatin
736
Nivolumab
681
Paclitaxel
635
Radiotherapy
618
Gemcitabine
580
Biopsy
560
Bevacizumab
486
Dexamethasone
444
fludarabine
410
Docetaxel
385
venetoclax
372
Oxaliplatin
367
Capecitabine
363
Fluorouracil
358
atezolizumab
353
durvalumab
340
Rituximab
336
Drug Therapy
334
Radiosurgery
321
Doxorubicin
320
Blood Specimen Collection
317
Standard of Care
311
Pemetrexed
308
Ipilimumab
303
Radiation
289
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Tumor Necrosis Factor-alpha
×
1 year
×
Clear all
NCT04695327
2026-03-06
TUNIMO
TILT Biotherapeutics Ltd.
Phase 1
Completed
32 enrolled
NCT05222932
2025-08-07
AVENTIL
TILT Biotherapeutics Ltd.
Phase 1
Active not recruiting
15 enrolled